Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

AbbVie (NYSE:ABBV) Trading Up 0.6% - Here's What Happened

AbbVie (NYSE:ABBV) Trading Up 0.9% - Still a Buy?

AbbVie (NYSE:ABBV) Earns "Buy" Rating from Guggenheim
Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?

Commerce Bank Purchases 152 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Shares Up 0.3% - What's Next?

FY2025 Earnings Estimate for AbbVie Issued By Zacks Research

AbbVie Inc. (NYSE:ABBV) Shares Acquired by CANADA LIFE ASSURANCE Co

Fairfield Bush & CO. Acquires 2,739 Shares of AbbVie Inc. (NYSE:ABBV)

20,000 Shares in AbbVie Inc. (NYSE:ABBV) Purchased by Ally Financial Inc.

Capital Group Private Client Services Inc. Has $82.07 Million Stock Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (ABBV) to Release Earnings on Friday | MarketBeat

AbbVie (NYSE:ABBV) Trading Down 1.8% - Time to Sell?
AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025

FY2025 Earnings Forecast for AbbVie Issued By Zacks Research

Marshall Wace LLP Boosts Stock Position in AbbVie Inc. (NYSE:ABBV)

NewEdge Advisors LLC Has $88.36 Million Stake in AbbVie Inc. (NYSE:ABBV)

Insigneo Advisory Services LLC Reduces Stake in AbbVie Inc. (NYSE:ABBV)

Gabelli Funds LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)

Polycythaemia vera

Biopharma Industry: Trump's Executive Order Could Help Innovation, but Range of Scenarios Still Open | Morningstar

Lifelong Wealth Advisors Inc. Invests $246,000 in AbbVie Inc. (NYSE:ABBV)

Main Street Financial Solutions LLC Has $3.44 Million Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now

MSH Capital Advisors LLC Takes $1.58 Million Position in AbbVie Inc. (NYSE:ABBV)

Finward Bancorp Invests $1.18 Million in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Stake Boosted by Regal Investment Advisors LLC

AbbVie Inc. (NYSE:ABBV) Shares Sold by United Capital Financial Advisors LLC

Bridgewater Associates LP Boosts Position in AbbVie Inc. (NYSE:ABBV)

10,455 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by AGP Franklin LLC

AbbVie Inc. (NYSE:ABBV) Shares Sold by Guggenheim Capital LLC

AbbVie (NYSE:ABBV) Trading Up 2.8% - Should You Buy?

AbbVie Asks Court to Extend Venclexta Cancer-Drug Patent's Life

United Capital Financial Advisors LLC Sells 5,199 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) is Regal Investment Advisors LLC's 9th Largest Position
AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In

AbbVie (NYSE:ABBV) Trading Up 2.8% - Still a Buy?

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

SageView Advisory Group LLC Purchases 5,327 Shares of AbbVie Inc. (NYSE:ABBV)

Savvy Advisors Inc. Boosts Stake in AbbVie Inc. (NYSE:ABBV)

Synovus Financial Corp Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Piper Sandler Projects Strong Growth for Lenz Therapeutics (LENZ) with LNZ100 | ABBV Stock News

AbbVie Inc. (NYSE:ABBV) Shares Sold by Granite Investment Partners LLC

CreativeOne Wealth LLC Grows Position in AbbVie Inc. (NYSE:ABBV)

Mariner LLC Purchases 25,669 Shares of AbbVie Inc. (NYSE:ABBV)
/Abbvie%20Inc%20logo%20and%20stock%20chart-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Earnings Preview: What to Expect From AbbVie's Report

How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives

Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?

AbbVie Inc. (NYSE:ABBV) Shares Bought by Advisors Capital Management LLC

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

Townsquare Capital LLC Has $28.09 Million Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Philadelphia Trust Co.

Petros Family Wealth LLC Purchases New Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Trading Down 2% - Time to Sell?

93,454 Shares in AbbVie Inc. (NYSE:ABBV) Purchased by Heritage Trust Co

Dymon Asia Capital Singapore PTE. LTD. Purchases Shares of 6,000 AbbVie Inc. (NYSE:ABBV)

AbbVie (ABBV) Faces Volatility Despite Positive Earnings in Q1 2025

Phoenix Financial Ltd. Sells 6,346 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Shares Down 5.6% - Should You Sell?

Under-the-radar drug stock has big rebound potential here despite turmoil, says Carter Worth

AbbVie Brings New Suits Against State Pharmacy Contract Laws

Here's Why Clearbridge Growth Strategy Sold AbbVie (ABBV) - Insider Monkey

Kennedy Capital Management LLC Buys 12,675 Shares of AbbVie Inc. (NYSE:ABBV)

Neuberger Berman Group LLC Sells 737,973 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Scotia Capital Inc.

AbbVie Inc. (NYSE:ABBV) Position Increased by F M Investments LLC

DRW Securities LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)

Dopamine Agonist Market Segmentation Analysis by Drug, Application, and Route of Administration

StockNews.com Downgrades AbbVie (NYSE:ABBV) to Buy

AbbVie (NYSE:ABBV) Shares Down 5.6% - What's Next?

Long-Term Stock Portfolio: 15 Best Stocks for 15 Years

CERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit | Morningstar

EnRich Financial Partners LLC Boosts Stock Holdings in AbbVie Inc. (NYSE:ABBV)

ABBV Stock Upgraded to Buy Amid Valuation Insights

AbbVie (NYSE:ABBV) Trading Down 4.6% - Time to Sell?

AbbVie (NYSE:ABBV) Shares Gap Down - Here's What Happened

Morgan Stanley Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock

CERE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

APG Asset Management US Inc. Trims Position in AbbVie Inc. (NYSE:ABBV)

CERE Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Filed on Behalf of Former CERE Shareholders | Markets Insider

AbbVie (NYSE:ABBV) Shares Down 1.2% - Here's What Happened

AbbVie Inc (ABBV) Trading Down 4.25% on Apr 9

AbbVie (NYSE:ABBV) Earns Neutral Rating from The Goldman Sachs Group

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | Markets Insider

AbbVie Inc. (NYSE:ABBV) Stock Holdings Increased by APG Asset Management N.V.

AbbVie's Rinvoq (ABBV) Receives EU Approval for Giant Cell Arteritis

AbbVie (ABBV): A Top Dividend Stock to Weather Economic Storms

Advisory Services Network LLC Sells 22,730 Shares of AbbVie Inc. (NYSE:ABBV)

Straightline Group LLC Takes $242,000 Position in AbbVie Inc. (NYSE:ABBV)

3,504 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Bernard Wealth Management Corp.

AbbVie Inc. (NYSE:ABBV) Shares Bought by Abacus FCF Advisors LLC

AbbVie (NYSE:ABBV) Stock Price Down 1.9% - Time to Sell?

Early Parkinson's Drug Hits Targets in Phase III Studies

Autologous T cell therapy for PRAME + advanced solid tumors in HLA-A*02 + patients: a phase 1 trial

Cerebral Palsy Market to Expand Significantly With a 3% CAGR Through 2034 | DelveInsight | ABNewswire

AbbVie (ABBV) Secures EU Approval for Rinvoq to Treat Giant Cell Arteritis

Schwab U.S. Dividend Equity ETF (SCHD) Offers Low-Cost Large Cap Value Exposure
Latest news

Morning Note: Fed Cautious on Tariffs; US-Japan Currency Tensions; Oil Up

Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold